Pharmaceutical Cartridges Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material Type, By Application, By Chamber Type, By Size, By Therapeutics Area, By End User, By Region & Competition, 2021-2031F

Description

The Global Pharmaceutical Cartridges Market is projected to expand from a valuation of USD 2.90 billion in 2025 to USD 4.55 billion by 2031, reflecting a compound annual growth rate of 7.81%. These specialized cylindrical vessels, manufactured from borosilicate glass or polymers, are critical components in drug delivery mechanisms like pen injectors and autoinjectors, ensuring exact dosage accuracy. The market is primarily propelled by the rising prevalence of chronic diseases requiring long-term treatment and a growing preference for patient-centric self-administration. Furthermore, the burgeoning biologics sector reinforces this demand, as it requires high-stability packaging to preserve drug safety and integrity throughout storage and use.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 2.90 Billion
Market Size 2031	USD 4.55 Billion
CAGR 2026-2031	7.81%
Fastest Growing Segment	Glass Cartridges
Largest Market	North America

Highlighting the scale of demand, the International Diabetes Federation reported that approximately 589 million adults were living with diabetes globally in 2024, emphasizing the critical need for dependable insulin delivery systems such as cartridge-based pens. Despite these strong growth indicators, market expansion faces potential hurdles due to the significant capital expenditure and technical intricacies involved in manufacturing. The rigorous regulatory requirements for sterility and dimensional precision demand sophisticated production environments, creating barriers that restrict rapid capacity scaling for new market entrants.

Market Driver

The surging global incidence of chronic conditions, specifically obesity and diabetes, serves as the central catalyst for the uptake of pharmaceutical cartridges. As the number of patients requiring long-term injectable therapies rises, there is an increased dependency on multidose pen injectors that utilize these polymer or glass reservoirs for precise self-administration. This trend is clearly illustrated by the high demand for glucagon-like peptide-1 (GLP-1) receptor agonists, which has required massive manufacturing adjustments to maintain supply. For example, Novo Nordisk's 2023 Annual Report noted that sales in its Diabetes and Obesity care division rose by 38% to DKK 215.1 billion, demonstrating the widespread adoption of these cartridge-based treatments.

Concurrently, the market is evolving due to the rapid growth of the biologics sector, which necessitates premium packaging solutions. Because biologics and biosimilars frequently feature complex molecular structures sensitive to container surfaces, specialized borosilicate glass or polymers are essential for maintaining stability. This shift is reflected in the financials of major component manufacturers; Schott Pharma's February 2024 media release regarding Q1 results indicated that revenue from high-value solutions, including advanced containment systems, rose to 53%. To sustain this growth and the wider injectable ecosystem, major pharmaceutical companies are investing heavily in infrastructure, such as Eli Lilly's 2024 commitment of an additional $5.3 billion to its Lebanon, Indiana facility to enhance active pharmaceutical ingredient production for injectables.

Market Challenge

The expansion of the pharmaceutical cartridge market is substantially constrained by the significant capital expenditure and technical complexity required for manufacturing. Developing these primary packaging components demands specialized facilities capable of meeting stringent regulatory standards for dimensional precision and sterility. These exacting requirements force manufacturers to make large upfront investments in cleanroom environments and advanced machinery, creating significant barriers to entry for new competitors while simultaneously restricting the ability of established players to quickly ramp up production. As a result, the industry struggles to align supply capabilities with the escalating demand for injectable therapies.

The consequences of these manufacturing obstacles are clearly visible in the frequent supply chain disruptions affecting the sterile injectables market. In 2024, the American Society of Health-System Pharmacists reported a record high of 323 active drug shortages, a crisis largely stemming from regulatory delays and manufacturing quality control challenges. This statistic highlights how the rigorous operational demands and compliance burdens involved in producing high-quality delivery systems directly hinder market liquidity and the stability of growth within the sector.

Market Trends

The market is undergoing a transformation with the introduction of large-volume cartridges tailored for wearable injectors, facilitating a transition from intravenous infusions to subcutaneous self-administration for complex biologics. Because high-viscosity formulations for autoimmune diseases and oncology often require doses surpassing the standard 3mL limit of pen injectors, manufacturers are creating 5mL to 10mL cartridges compatible with on-body delivery devices. This innovation reduces reliance on healthcare facilities by enabling home management of chronic conditions. As noted in Schott Pharma's 2024 Annual Report, the revenue share of high-value solutions-including these large-volume cartridges-rose to 55% of total sales following a 22% year-on-year increase, signaling their vital importance in modern delivery.

At the same time, the industry is widely adopting Ready-to-Use (RTU) sterile cartridge formats, which significantly streamline the fill-finish process for pharmaceutical developers. By outsourcing sterilization, washing, and siliconization to the packaging supplier, drug manufacturers can bypass capital-intensive front-end processing lines and gain operational flexibility for small-batch therapies. This trend is accelerating as major suppliers standardize RTU platforms for filling line compatibility. For instance, Stevanato Group's Third Quarter 2025 Financial Results reported a 47% year-over-year surge in revenue from high-value solutions, including the EZ-fill RTU portfolio, reaching €147.9 million and highlighting the rapid adoption of pre-sterilized containment systems.

Key Market Players

Schott AG
Gerresheimer AG
West Pharmaceutical Services, Inc.
Stevanato Group
Nipro Corporation
Berry Global Group, Inc.
SGD Pharma
Baxter International Inc.
Vetter Pharma International GmbH
Catalent, Inc.

Report Scope

In this report, the Global Pharmaceutical Cartridges Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Cartridges Market, By Material Type

Glass Cartridges
Plastic Cartridges
Rubber

Pharmaceutical Cartridges Market, By Application

Dental Anesthesia
Pen Injectors
Autoinjectors
Wearable Injectors

Pharmaceutical Cartridges Market, By Chamber Type

Dual Chamber
Large Volume

Pharmaceutical Cartridges Market, By Size

0.5ml
1.8ml
2ml to 2.5ml
3ml
5ml
More than 10ml

Pharmaceutical Cartridges Market, By Therapeutics Area

Ophthalmology
Respiratory
Neurology
Oncology
Immunology
Cardiology
Diabetes
Dental
Others

Pharmaceutical Cartridges Market, By End User

Pharmaceuticals
Biotechnology
Research Organizations
Others

Pharmaceutical Cartridges Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Cartridges Market.

Available Customizations:

Global Pharmaceutical Cartridges Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Cartridges Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Material Type (Glass Cartridges, Plastic Cartridges, Rubber)
- 5.2.2. By Application (Dental Anesthesia, Pen Injectors, Autoinjectors, Wearable Injectors)
- 5.2.3. By Chamber Type (Dual Chamber, Large Volume)
- 5.2.4. By Size (0.5ml, 1.8ml, 2ml to 2.5ml, 3ml, 5ml, More than 10ml)
- 5.2.5. By Therapeutics Area (Ophthalmology, Respiratory, Neurology, Oncology, Immunology, Cardiology, Diabetes, Dental, Others)
- 5.2.6. By End User (Pharmaceuticals, Biotechnology, Research Organizations, Others)
- 5.2.7. By Region
- 5.2.8. By Company (2025)
5.3. Market Map

6. North America Pharmaceutical Cartridges Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Material Type
- 6.2.2. By Application
- 6.2.3. By Chamber Type
- 6.2.4. By Size
- 6.2.5. By Therapeutics Area
- 6.2.6. By End User
- 6.2.7. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Pharmaceutical Cartridges Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Material Type
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By Chamber Type
    - 6.3.1.2.4. By Size
    - 6.3.1.2.5. By Therapeutics Area
    - 6.3.1.2.6. By End User
- 6.3.2. Canada Pharmaceutical Cartridges Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Material Type
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By Chamber Type
    - 6.3.2.2.4. By Size
    - 6.3.2.2.5. By Therapeutics Area
    - 6.3.2.2.6. By End User
- 6.3.3. Mexico Pharmaceutical Cartridges Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Material Type
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By Chamber Type
    - 6.3.3.2.4. By Size
    - 6.3.3.2.5. By Therapeutics Area
    - 6.3.3.2.6. By End User

7. Europe Pharmaceutical Cartridges Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Material Type
- 7.2.2. By Application
- 7.2.3. By Chamber Type
- 7.2.4. By Size
- 7.2.5. By Therapeutics Area
- 7.2.6. By End User
- 7.2.7. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Pharmaceutical Cartridges Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Material Type
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By Chamber Type
    - 7.3.1.2.4. By Size
    - 7.3.1.2.5. By Therapeutics Area
    - 7.3.1.2.6. By End User
- 7.3.2. France Pharmaceutical Cartridges Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Material Type
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By Chamber Type
    - 7.3.2.2.4. By Size
    - 7.3.2.2.5. By Therapeutics Area
    - 7.3.2.2.6. By End User
- 7.3.3. United Kingdom Pharmaceutical Cartridges Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Material Type
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By Chamber Type
    - 7.3.3.2.4. By Size
    - 7.3.3.2.5. By Therapeutics Area
    - 7.3.3.2.6. By End User
- 7.3.4. Italy Pharmaceutical Cartridges Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Material Type
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By Chamber Type
    - 7.3.4.2.4. By Size
    - 7.3.4.2.5. By Therapeutics Area
    - 7.3.4.2.6. By End User
- 7.3.5. Spain Pharmaceutical Cartridges Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Material Type
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By Chamber Type
    - 7.3.5.2.4. By Size
    - 7.3.5.2.5. By Therapeutics Area
    - 7.3.5.2.6. By End User

8. Asia Pacific Pharmaceutical Cartridges Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Material Type
- 8.2.2. By Application
- 8.2.3. By Chamber Type
- 8.2.4. By Size
- 8.2.5. By Therapeutics Area
- 8.2.6. By End User
- 8.2.7. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Pharmaceutical Cartridges Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Material Type
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By Chamber Type
    - 8.3.1.2.4. By Size
    - 8.3.1.2.5. By Therapeutics Area
    - 8.3.1.2.6. By End User
- 8.3.2. India Pharmaceutical Cartridges Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Material Type
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By Chamber Type
    - 8.3.2.2.4. By Size
    - 8.3.2.2.5. By Therapeutics Area
    - 8.3.2.2.6. By End User
- 8.3.3. Japan Pharmaceutical Cartridges Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Material Type
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By Chamber Type
    - 8.3.3.2.4. By Size
    - 8.3.3.2.5. By Therapeutics Area
    - 8.3.3.2.6. By End User
- 8.3.4. South Korea Pharmaceutical Cartridges Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Material Type
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By Chamber Type
    - 8.3.4.2.4. By Size
    - 8.3.4.2.5. By Therapeutics Area
    - 8.3.4.2.6. By End User
- 8.3.5. Australia Pharmaceutical Cartridges Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Material Type
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By Chamber Type
    - 8.3.5.2.4. By Size
    - 8.3.5.2.5. By Therapeutics Area
    - 8.3.5.2.6. By End User

9. Middle East & Africa Pharmaceutical Cartridges Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Material Type
- 9.2.2. By Application
- 9.2.3. By Chamber Type
- 9.2.4. By Size
- 9.2.5. By Therapeutics Area
- 9.2.6. By End User
- 9.2.7. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Pharmaceutical Cartridges Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Material Type
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By Chamber Type
    - 9.3.1.2.4. By Size
    - 9.3.1.2.5. By Therapeutics Area
    - 9.3.1.2.6. By End User
- 9.3.2. UAE Pharmaceutical Cartridges Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Material Type
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By Chamber Type
    - 9.3.2.2.4. By Size
    - 9.3.2.2.5. By Therapeutics Area
    - 9.3.2.2.6. By End User
- 9.3.3. South Africa Pharmaceutical Cartridges Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Material Type
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By Chamber Type
    - 9.3.3.2.4. By Size
    - 9.3.3.2.5. By Therapeutics Area
    - 9.3.3.2.6. By End User

10. South America Pharmaceutical Cartridges Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Material Type
- 10.2.2. By Application
- 10.2.3. By Chamber Type
- 10.2.4. By Size
- 10.2.5. By Therapeutics Area
- 10.2.6. By End User
- 10.2.7. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Pharmaceutical Cartridges Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Material Type
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By Chamber Type
    - 10.3.1.2.4. By Size
    - 10.3.1.2.5. By Therapeutics Area
    - 10.3.1.2.6. By End User
- 10.3.2. Colombia Pharmaceutical Cartridges Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Material Type
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By Chamber Type
    - 10.3.2.2.4. By Size
    - 10.3.2.2.5. By Therapeutics Area
    - 10.3.2.2.6. By End User
- 10.3.3. Argentina Pharmaceutical Cartridges Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Material Type
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By Chamber Type
    - 10.3.3.2.4. By Size
    - 10.3.3.2.5. By Therapeutics Area
    - 10.3.3.2.6. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Pharmaceutical Cartridges Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Schott AG
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Gerresheimer AG
15.3. West Pharmaceutical Services, Inc.
15.4. Stevanato Group
15.5. Nipro Corporation
15.6. Berry Global Group, Inc.
15.7. SGD Pharma
15.8. Baxter International Inc.
15.9. Vetter Pharma International GmbH
15.10. Catalent, Inc.